Skip to Main Content

Paper Details

Synthetic lethal therapies for cancer: what's next after PARP inhibitors?
Nat Rev Clin Oncol
257
2018
Author NameAffiliation
Alan AshworthUCSF Helen Diller Family Comprehensive Cancer Center
  • 1 - 1

Datasets

Release 1.2